Published on in Vol 8, No 10 (2020): October
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/22108, first published
.
![Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study](https://asset.jmir.pub/assets/28259edd7a0a41f1ecc1040137d3586b.png 480w,https://asset.jmir.pub/assets/28259edd7a0a41f1ecc1040137d3586b.png 960w,https://asset.jmir.pub/assets/28259edd7a0a41f1ecc1040137d3586b.png 1920w,https://asset.jmir.pub/assets/28259edd7a0a41f1ecc1040137d3586b.png 2500w)
1 Sage Bionetworks, Seattle, WA, United States
2 Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
3 Providence Multiple Sclerosis Center, Providence St Vincent Medical Center, Portland, OR, United States